Thermo Fisher Scientific Inc. (TMO)
Price:
539.17 USD
( - -4.78 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)

(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Waters Corporation
VALUE SCORE:
6
2nd position
Danaher Corporation
VALUE SCORE:
7
The best
Quest Diagnostics Incorporated
VALUE SCORE:
9
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
NEWS

Thermo Fisher's New R&D Alliance With AstraZeneca May Lift Its Stock
zacks.com
2025-10-07 09:41:05TMO joins AstraZeneca's BioVentureHub to boost R&D, innovation and life science access.

Top 15 High-Growth Dividend Stocks For October 2025
seekingalpha.com
2025-10-01 22:58:24The Top 15 High-Growth Dividend Stock list for October 2025 targets a 12% long-term return, despite underperforming SPY and VIG in September. These 15 stocks offer a 1.4% average yield and have grown dividends at 19.1% annually over five years, with many trading at significant discounts. Recent changes include six new additions, with expected long-term CAGRs near 20% based on dividend yield theory and valuation metrics.

Thermo Fisher Scientific Announces R&D Partnership with AstraZeneca BioVentureHub
businesswire.com
2025-10-01 10:59:00WILMINGTON, N.C.--(BUSINESS WIRE)--Thermo Fisher Scientific announces R&D partnership with AstraZeneca BioVentureHub.

Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 22, 2025
businesswire.com
2025-10-01 08:00:00WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter 2025 before the market opens on Wednesday, October 22, 2025, and will hold a conference call on the same day at 8:30 a.m. ET. During the call, the company will discuss its financial performance, as well as future expectations. To listen, call (833) 470-1428 within the U.S. or (404) 975-4839 outside the U.S. Th.

Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes
businesswire.com
2025-09-30 20:00:00WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that it has priced an offering of $2.5 billion aggregate principal amount (the “Offering”) of the following notes: $500 million aggregate principal amount of its 4.200% senior notes due 2031 (the “2031 notes”) at the issue price of 99.874% of their principal amount; $750 million aggregate principal amount of its 4.473% senior notes due 2032 (the “2032 notes”) at the issue price of 100.00.

Thermo Fisher Scientific Shares Up 3.3% After Power Inflow Signal
benzinga.com
2025-09-30 14:54:39Thermo Fisher Scientific Inc (NYSE:TMO) experienced a significant Power Inflow alert, a key bullish indicator that is closely tracked by traders who value order flow analytics, specifically institutional and retail order flow data.At 10:36 AM EST on September 30, TMO triggered a Power Inflow signal at a price of $464.71. Prior to the alert, TMO had been stagnant during the first hour of trading, with the stock price not moving far off the opening price.

Thermo Fisher Scientific Showcases the Thermo Fisher Connect Platform at Lab of the Future Europe
businesswire.com
2025-09-30 08:30:00WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, is sponsoring Lab of the Future Europe this week in Amsterdam, The Netherlands, and will demonstrate how the company's Thermo Fisher™ Connect Platform can integrate and future-proof laboratories. From Digital Ambition to Automated Intelligence In pharma and life sciences, digital transformation is no longer a question of if — but how fast. Many labs remain stuck in a cycle of technical debt and shado.

BenchSci Announces Strategic Partnership with Thermo Fisher Scientific to Create AI-powered Tools to Accelerate R&D Productivity
businesswire.com
2025-09-30 08:00:00TORONTO--(BUSINESS WIRE)--BenchSci today announced a strategic partnership with Thermo Fisher Scientific Inc. to create AI-powered tools to accelerate R&D productivity.

Dr. Park CDMO Selects Thermo Fisher Scientific to Equip New Viral Vector Manufacturing Facility
businesswire.com
2025-09-24 20:00:00WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced that Dr. Park, an emerging viral vector contract development and manufacturing organization (CDMO) based in South Korea, has selected Thermo Fisher to provide advanced bioreactors and consumables for its newest facility. Dr. Park specializes in Adeno-associated virus-based (AAV-based) viral vector production and currently at 5,000 L per batch, producing up to 40 clinical-grade ba.

Thermo Fisher: A Wide-Moat Leader With Multi-Year Growth Ahead
seekingalpha.com
2025-09-24 08:37:49Thermo Fisher is well positioned as a mission-critical partner in life sciences, with a recurring revenue base and strong end-to-end solutions. The company's strategic acquisitions and leadership in bioprocessing, cell and gene therapy as well as multi-omics reinforce its competitive moat and growth potential. Thermo Fisher's unmatched global distribution drives cross-selling, allowing customers to take advantage of the company's diverse offerings.

HOLX vs. TMO: Which Diagnostic Giant Is the Stronger Buy Today?
zacks.com
2025-09-22 10:25:45Diagnostic leaders Hologic and Thermo Fisher post raised outlooks, acquisitions and strong product momentum.

Thermo Fisher Scientific Launches the Thermo Scientific Hypulse Surface Analysis System to Accelerate the Understanding of Material Surfaces
businesswire.com
2025-09-22 08:30:00WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Hypulse™ Surface Analysis System. This innovative surface analysis instrument represents a leap forward in accurate X-ray photoelectron spectroscopy (XPS) depth-profiling, which is critical for materials scientists around the world. Innovation to Improve Society The Hypulse Surface Analysis System will enable the development of surfaces across industries to impro.

Thirty Inspiring Middle School Scientists and Engineers Shine as Finalists in the Thermo Fisher Scientific Junior Innovators Challenge
globenewswire.com
2025-09-17 12:05:00WASHINGTON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Society for Science today announced the 30 finalists in the Thermo Fisher Scientific Junior Innovators Challenge (Thermo Fisher JIC), the nation's premier middle school science, technology, engineering and mathematics (STEM) competition.

The New Olink Target 48 Neurodegeneration Panel May Boost TMO Stock
zacks.com
2025-09-16 11:46:10Thermo Fisher unveils the Olink Target 48 Neurodegeneration panel to accelerate biomarker research in neurodegenerative diseases.

Thermo Fisher Scientific Expands Neurodegeneration Research Capabilities with Launch of Olink® Target 48 Neurodegeneration Panel
businesswire.com
2025-09-15 16:15:00WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the Olink® Target 48 Neurodegeneration panel, a high-performance, targeted proteomics immunoassay panel developed to accelerate discoveries in neurodegenerative disease research. With diseases such as Alzheimer's, multiple sclerosis and Parkinson's on the rise and clinical pipelines eager for translational biomarkers, researchers face a pressing need for scalable, r.

Thermo Fisher Scientific Inc. (TMO) J.P. Morgan CEO Call Series Call (Transcript)
seekingalpha.com
2025-09-05 16:49:15Thermo Fisher Scientific Inc. J.P. Morgan CEO Call Series September 5, 2025 1:00 PM EDT Company Participants Marc Casper - Chairman, President & CEO Conference Call Participants Rachel Vatnsdal Olson - JPMorgan Chase & Co, Research Division Presentation Operator Welcome, and thank you for standing by.

Thermo Fisher's New R&D Alliance With AstraZeneca May Lift Its Stock
zacks.com
2025-10-07 09:41:05TMO joins AstraZeneca's BioVentureHub to boost R&D, innovation and life science access.

Top 15 High-Growth Dividend Stocks For October 2025
seekingalpha.com
2025-10-01 22:58:24The Top 15 High-Growth Dividend Stock list for October 2025 targets a 12% long-term return, despite underperforming SPY and VIG in September. These 15 stocks offer a 1.4% average yield and have grown dividends at 19.1% annually over five years, with many trading at significant discounts. Recent changes include six new additions, with expected long-term CAGRs near 20% based on dividend yield theory and valuation metrics.

Thermo Fisher Scientific Announces R&D Partnership with AstraZeneca BioVentureHub
businesswire.com
2025-10-01 10:59:00WILMINGTON, N.C.--(BUSINESS WIRE)--Thermo Fisher Scientific announces R&D partnership with AstraZeneca BioVentureHub.

Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 22, 2025
businesswire.com
2025-10-01 08:00:00WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter 2025 before the market opens on Wednesday, October 22, 2025, and will hold a conference call on the same day at 8:30 a.m. ET. During the call, the company will discuss its financial performance, as well as future expectations. To listen, call (833) 470-1428 within the U.S. or (404) 975-4839 outside the U.S. Th.

Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes
businesswire.com
2025-09-30 20:00:00WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that it has priced an offering of $2.5 billion aggregate principal amount (the “Offering”) of the following notes: $500 million aggregate principal amount of its 4.200% senior notes due 2031 (the “2031 notes”) at the issue price of 99.874% of their principal amount; $750 million aggregate principal amount of its 4.473% senior notes due 2032 (the “2032 notes”) at the issue price of 100.00.

Thermo Fisher Scientific Shares Up 3.3% After Power Inflow Signal
benzinga.com
2025-09-30 14:54:39Thermo Fisher Scientific Inc (NYSE:TMO) experienced a significant Power Inflow alert, a key bullish indicator that is closely tracked by traders who value order flow analytics, specifically institutional and retail order flow data.At 10:36 AM EST on September 30, TMO triggered a Power Inflow signal at a price of $464.71. Prior to the alert, TMO had been stagnant during the first hour of trading, with the stock price not moving far off the opening price.

Thermo Fisher Scientific Showcases the Thermo Fisher Connect Platform at Lab of the Future Europe
businesswire.com
2025-09-30 08:30:00WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, is sponsoring Lab of the Future Europe this week in Amsterdam, The Netherlands, and will demonstrate how the company's Thermo Fisher™ Connect Platform can integrate and future-proof laboratories. From Digital Ambition to Automated Intelligence In pharma and life sciences, digital transformation is no longer a question of if — but how fast. Many labs remain stuck in a cycle of technical debt and shado.

BenchSci Announces Strategic Partnership with Thermo Fisher Scientific to Create AI-powered Tools to Accelerate R&D Productivity
businesswire.com
2025-09-30 08:00:00TORONTO--(BUSINESS WIRE)--BenchSci today announced a strategic partnership with Thermo Fisher Scientific Inc. to create AI-powered tools to accelerate R&D productivity.

Dr. Park CDMO Selects Thermo Fisher Scientific to Equip New Viral Vector Manufacturing Facility
businesswire.com
2025-09-24 20:00:00WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced that Dr. Park, an emerging viral vector contract development and manufacturing organization (CDMO) based in South Korea, has selected Thermo Fisher to provide advanced bioreactors and consumables for its newest facility. Dr. Park specializes in Adeno-associated virus-based (AAV-based) viral vector production and currently at 5,000 L per batch, producing up to 40 clinical-grade ba.

Thermo Fisher: A Wide-Moat Leader With Multi-Year Growth Ahead
seekingalpha.com
2025-09-24 08:37:49Thermo Fisher is well positioned as a mission-critical partner in life sciences, with a recurring revenue base and strong end-to-end solutions. The company's strategic acquisitions and leadership in bioprocessing, cell and gene therapy as well as multi-omics reinforce its competitive moat and growth potential. Thermo Fisher's unmatched global distribution drives cross-selling, allowing customers to take advantage of the company's diverse offerings.

HOLX vs. TMO: Which Diagnostic Giant Is the Stronger Buy Today?
zacks.com
2025-09-22 10:25:45Diagnostic leaders Hologic and Thermo Fisher post raised outlooks, acquisitions and strong product momentum.

Thermo Fisher Scientific Launches the Thermo Scientific Hypulse Surface Analysis System to Accelerate the Understanding of Material Surfaces
businesswire.com
2025-09-22 08:30:00WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Hypulse™ Surface Analysis System. This innovative surface analysis instrument represents a leap forward in accurate X-ray photoelectron spectroscopy (XPS) depth-profiling, which is critical for materials scientists around the world. Innovation to Improve Society The Hypulse Surface Analysis System will enable the development of surfaces across industries to impro.

Thirty Inspiring Middle School Scientists and Engineers Shine as Finalists in the Thermo Fisher Scientific Junior Innovators Challenge
globenewswire.com
2025-09-17 12:05:00WASHINGTON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Society for Science today announced the 30 finalists in the Thermo Fisher Scientific Junior Innovators Challenge (Thermo Fisher JIC), the nation's premier middle school science, technology, engineering and mathematics (STEM) competition.

The New Olink Target 48 Neurodegeneration Panel May Boost TMO Stock
zacks.com
2025-09-16 11:46:10Thermo Fisher unveils the Olink Target 48 Neurodegeneration panel to accelerate biomarker research in neurodegenerative diseases.

Thermo Fisher Scientific Expands Neurodegeneration Research Capabilities with Launch of Olink® Target 48 Neurodegeneration Panel
businesswire.com
2025-09-15 16:15:00WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the Olink® Target 48 Neurodegeneration panel, a high-performance, targeted proteomics immunoassay panel developed to accelerate discoveries in neurodegenerative disease research. With diseases such as Alzheimer's, multiple sclerosis and Parkinson's on the rise and clinical pipelines eager for translational biomarkers, researchers face a pressing need for scalable, r.

Thermo Fisher Scientific Inc. (TMO) J.P. Morgan CEO Call Series Call (Transcript)
seekingalpha.com
2025-09-05 16:49:15Thermo Fisher Scientific Inc. J.P. Morgan CEO Call Series September 5, 2025 1:00 PM EDT Company Participants Marc Casper - Chairman, President & CEO Conference Call Participants Rachel Vatnsdal Olson - JPMorgan Chase & Co, Research Division Presentation Operator Welcome, and thank you for standing by.